2024 Corporate Sustainability Performance in the Biotechnologies & Pharmaceutical sector

Please fill out the form
to download the file

This report provides a detailed analysis of the sustainability performance of 86 European companies in the Biotechnologies & Pharmaceuticals sector, based on EthiFinance’s ESG Ratings assessment conducted in 2024 with data reported for fiscal year 2023. The study highlights key trends and findings on the sector’s most material aspects across the four sustainability pillars—Environmental, Social, Governance, and External Stakeholders, offering insights into progress and challenges in sustainable practices.

Promoting informed & responsible decision-making for a more sustainable finance and economy.

ESG Rating Agency

Helping investors to make informed and responsible decisions
Learn More

Credit Rating Agency

Helping companies to ensure transparency and facilitate their access to finance
Learn More
Get in Touch

Your information is used solely by EthiFinance to manage your request and/or complaints raised before it for which you are giving your explicit consent. Mandatory fields are marked with an asterisk; your request may not be addressed in the absence of such information. We inform you that you may exercise your rights of access, rectification, erasure, object, portability, restriction in processing and to be forgotten by contacting our Group DPO at the following address: dpo@ethifinance.com. For more information on the processing of your personal data by EthiFinance, please refer to our privacy policy available on our website at the following address: Privacy Policy